Form 4: Celularity Inc: Insider Transactions Reveal Warrant Amendments by Major Shareholders
SEC Form 4
Lim Kok Thay, along with Dragasac Limited and Genting Berhad, reports transactions involving Class A Common Stock and warrant amendments related to Celularity Inc.
Summary
- This Form 4 filing details changes in beneficial ownership of Celularity Inc. (CELU) securities by Lim Kok Thay, Dragasac Limited, and Genting Berhad.
- The transactions involve Class A Common Stock and warrants.
- On January 24, 2025, the exercise price of warrants held by Dragasac Limited was adjusted from $2.4898 to $2.07 per share.
- These warrants were initially received in connection with the merger of GX Acquisition Corp. and Celularity on July 16, 2021, and a securities purchase agreement on January 12, 2024.
- The reported transactions reflect acquisitions and disposals of securities, as well as amendments to warrant terms.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing insider transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency regarding insider transactions in publicly traded companies. This filing indicates activity by significant shareholders and a director of Celularity Inc.
Stakeholder Impact
- Shareholders may be interested in the transactions of major shareholders and directors, as these can sometimes indicate confidence (or lack thereof) in the company's future prospects.
- The warrant amendment could potentially dilute existing shareholders if the warrants are exercised.
Key Dates
| Date | Description |
|---|---|
| 07/16/2021 | Date of merger between GX Acquisition Corp. and Celularity, in connection with which Dragasac received warrants. |
| 01/12/2024 | Date of securities purchase agreement between Celularity and Dragasac, in connection with which Dragasac received warrants. |
| 01/16/2024 | Original exercisable date of warrants. |
| 02/28/2024 | Date of the 1-for-10 reverse stock split. |
| 01/24/2025 | Date of warrant amendment, adjusting the exercise price to $2.07. |
| 01/28/2025 | Date of filing. |
| 01/16/2029 | Expiration date of warrants. |
| 03/16/2030 | Expiration date of warrants. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.